tiprankstipranks
Trending News
More News >
Genscript Biotech (GNNSF)
OTHER OTC:GNNSF
US Market

Genscript Biotech (GNNSF) Ratios

Compare
19 Followers

Genscript Biotech Ratios

GNNSF's free cash flow for Q2 2025 was $0.62. For the 2025 fiscal year, GNNSF's free cash flow was decreased by $ and operating cash flow was $0.35. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.47 2.72 4.76 3.23 3.97
Quick Ratio
1.41 2.62 4.65 3.12 3.86
Cash Ratio
0.24 0.43 2.92 1.88 2.86
Solvency Ratio
-0.53 3.17 -0.02 -0.15 -0.38
Operating Cash Flow Ratio
0.32 0.25 -0.58 -0.22 -0.33
Short-Term Operating Cash Flow Coverage
0.50 0.85 -5.03 -3.57 -262.55
Net Current Asset Value
$ 180.58M$ -119.93M$ 1.01B$ 581.24M$ 792.88M
Leverage Ratios
Debt-to-Assets Ratio
0.11 0.14 0.12 0.14 0.07
Debt-to-Equity Ratio
0.13 0.17 0.30 0.35 0.15
Debt-to-Capital Ratio
0.12 0.14 0.23 0.26 0.13
Long-Term Debt-to-Capital Ratio
0.00 0.12 0.17 0.21 0.10
Financial Leverage Ratio
1.23 1.22 2.44 2.52 2.14
Debt Service Coverage Ratio
0.55 0.70 -3.00 -8.21 -164.96
Interest Coverage Ratio
31.50 1.16 0.95 -33.02 -159.50
Debt to Market Cap
0.14 0.24 0.07 0.04 0.01
Interest Debt Per Share
0.24 0.34 0.21 0.17 0.08
Net Debt to EBITDA
1.08 8.40 4.13 1.73 2.15
Profitability Margins
Gross Profit Margin
57.65%45.77%32.24%48.60%57.65%
EBIT Margin
26.59%1.56%-38.53%-70.00%-105.08%
EBITDA Margin
33.78%11.85%-29.71%-62.18%-97.38%
Operating Profit Margin
26.59%1.56%3.12%-70.02%-77.39%
Pretax Profit Margin
-49.09%-28.73%-41.81%-68.99%-105.56%
Net Profit Margin
-55.58%498.22%-11.37%-36.26%-73.19%
Continuous Operations Profit Margin
-55.54%-29.23%19.40%-68.40%-105.76%
Net Income Per EBT
113.23%-1734.15%27.20%52.55%69.33%
EBT Per EBIT
-184.59%-1840.09%-1339.92%98.53%136.40%
Return on Assets (ROA)
-11.00%56.11%-2.82%-8.91%-16.06%
Return on Equity (ROE)
-12.75%68.54%-6.86%-22.45%-34.29%
Return on Capital Employed (ROCE)
6.18%0.19%0.91%-21.90%-20.83%
Return on Invested Capital (ROIC)
5.55%0.18%0.89%-22.50%-21.31%
Return on Tangible Assets
-11.03%56.27%-2.84%-9.00%-16.35%
Earnings Yield
-16.40%107.38%-1.86%-3.40%-3.99%
Efficiency Ratios
Receivables Turnover
7.17 5.01 3.84 6.00 3.44
Payables Turnover
11.06 10.80 7.25 5.77 6.88
Inventory Turnover
10.27 10.37 5.43 5.37 4.68
Fixed Asset Turnover
1.54 1.00 1.12 1.00 1.01
Asset Turnover
0.20 0.11 0.25 0.25 0.22
Working Capital Turnover Ratio
2.10 0.50 0.55 0.51 0.52
Cash Conversion Cycle
53.42 74.31 112.00 65.57 131.02
Days of Sales Outstanding
50.90 72.89 95.14 60.83 106.08
Days of Inventory Outstanding
35.53 35.21 67.18 68.02 78.00
Days of Payables Outstanding
33.01 33.78 50.32 63.28 53.06
Operating Cycle
86.43 108.10 162.32 128.85 184.08
Cash Flow Ratios
Operating Cash Flow Per Share
0.11 0.03 -0.14 -0.06 -0.07
Free Cash Flow Per Share
0.09 -0.03 -0.21 -0.16 -0.13
CapEx Per Share
0.01 0.07 0.07 0.10 0.07
Free Cash Flow to Operating Cash Flow
0.86 -0.96 1.55 2.80 1.97
Dividend Paid and CapEx Coverage Ratio
7.24 0.51 -1.82 -0.56 -1.03
Capital Expenditure Coverage Ratio
7.24 0.51 -1.82 -0.56 -1.03
Operating Cash Flow Coverage Ratio
0.44 0.10 -0.69 -0.34 -0.87
Operating Cash Flow to Sales Ratio
0.24 0.13 -0.34 -0.19 -0.28
Free Cash Flow Yield
6.19%-2.62%-8.66%-5.04%-3.00%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-6.10 0.93 -53.79 -29.40 -25.04
Price-to-Sales (P/S) Ratio
3.38 4.64 6.12 10.66 18.32
Price-to-Book (P/B) Ratio
0.82 0.64 3.69 6.60 8.59
Price-to-Free Cash Flow (P/FCF) Ratio
16.17 -38.16 -11.55 -19.83 -33.28
Price-to-Operating Cash Flow Ratio
14.00 36.46 -17.90 -55.44 -65.65
Price-to-Earnings Growth (PEG) Ratio
<0.01 -0.03 0.91 0.76 -0.39
Price-to-Fair Value
0.82 0.64 3.69 6.60 8.59
Enterprise Value Multiple
11.07 47.57 -16.46 -15.41 -16.67
Enterprise Value
3.59B 3.35B 4.11B 6.00B 7.96B
EV to EBITDA
11.07 47.57 -16.46 -15.41 -16.67
EV to Sales
3.74 5.64 4.89 9.58 16.23
EV to Free Cash Flow
17.91 -46.35 -9.23 -17.82 -29.49
EV to Operating Cash Flow
15.43 44.28 -14.31 -49.84 -58.17
Tangible Book Value Per Share
1.80 1.98 0.96 0.64 0.66
Shareholders’ Equity Per Share
1.80 1.98 0.66 0.48 0.52
Tax and Other Ratios
Effective Tax Rate
-0.13 -0.02 -0.01 <0.01 >-0.01
Revenue Per Share
0.44 0.27 0.40 0.30 0.24
Net Income Per Share
-0.24 1.36 -0.05 -0.11 -0.18
Tax Burden
1.13 -17.34 0.27 0.53 0.69
Interest Burden
-1.85 -18.40 1.09 0.99 1.00
Research & Development to Revenue
0.07 0.09 0.52 0.62 0.73
SG&A to Revenue
0.07 0.19 0.25 0.29 0.27
Stock-Based Compensation to Revenue
<0.01 0.03 0.07 0.10 0.08
Income Quality
-9.14 0.03 0.82 0.53 0.38
Currency in USD